| 1 |
35216325 | A Transcriptomic Approach to Elucidate the Mechanisms of Gefitinib-Induced Toxicity in Healthy Human Intestinal Organoids. | 2022 Feb 17 |
1 |
| 2 |
34192651 | TP53 mutations in circulating tumor DNA in advanced epidermal growth factor receptor-mutant lung adenocarcinoma patients treated with gefitinib. | 2021 Sep |
2 |
| 3 |
34370268 | STAT3 inhibitor BBI608 enhances the antitumor effect of gefitinib on EGFR-mutated non-small cell lung cancer cells. | 2021 Nov |
2 |
| 4 |
34445495 | Gain-of-Function Mutant TP53 R248Q Overexpressed in Epithelial Ovarian Carcinoma Alters AKT-Dependent Regulation of Intercellular Trafficking in Responses to EGFR/MDM2 Inhibitor. | 2021 Aug 16 |
3 |
| 5 |
34799910 | P1-39: Paclitaxel induces growth inhibition in gefitinib-resistant PC9-MET cells by downregulating MDM2 and activating p53. | 2021 Nov |
1 |
| 6 |
35273907 | The Landscape of Actionable Genomic Alterations by Next-Generation Sequencing in Tumor Tissue Versus Circulating Tumor DNA in Chinese Patients With Non-Small Cell Lung Cancer. | 2021 |
1 |
| 7 |
32742376 | TP53 mutation influences the efficacy of treatment of colorectal cancer cell lines with a combination of sirtuin inhibitors and chemotherapeutic agents. | 2020 Aug |
1 |
| 8 |
33089100 | Matrix Metalloprotease-7 Mediates Nucleolar Assembly and Intra-nucleolar Cleaving p53 in Gefitinib-Resistant Cancer Stem Cells. | 2020 Oct 23 |
2 |
| 9 |
31168030 | The anti-cancer drug gefitinib accelerates Fas-mediated apoptosis by enhancing caspase-8 activation in cancer cells. | 2019 |
1 |
| 10 |
28247504 | Epigallocatechin-3-gallate augments the therapeutic effects of benzo[a]pyrene-mediated lung carcinogenesis. | 2017 Jul 8 |
1 |
| 11 |
28529576 | Increased MIR31HG lncRNA expression increases gefitinib resistance in non-small cell lung cancer cell lines through the EGFR/PI3K/AKT signaling pathway. | 2017 May |
1 |
| 12 |
30641628 | [Effect of Fuzheng Kang'ai Recipe Combined Gefitinib on Lung Cancer A549 Cells and Its Mecha- nism Research]. | 2016 Nov |
1 |
| 13 |
25501339 | Ad-p53 enhances the sensitivity of triple-negative breast cancer MDA-MB-468 cells to the EGFR inhibitor gefitinib. | 2015 Feb |
2 |
| 14 |
25623760 | [Effect of recombinant human p53 adenovirus (Ad-p53) combined with EGFR inhibitor gefitinib on the sensitivity of breast cancer MDA-MB-468 cells]. | 2014 Dec |
4 |
| 15 |
21216229 | Aurora-A promotes gefitinib resistance via a NF-κB signaling pathway in p53 knockdown lung cancer cells. | 2011 Feb 11 |
8 |
| 16 |
21406185 | Suppression of Stat3 activity sensitizes gefitinib-resistant non small cell lung cancer cells. | 2011 Jun 1 |
2 |
| 17 |
18973751 | An epidermal growth factor inhibitor, Gefitinib, induces apoptosis through a p53-dependent upregulation of pro-apoptotic molecules and downregulation of anti-apoptotic molecules in human lung adenocarcinoma A549 cells. | 2008 Dec 14 |
7 |
| 18 |
17283151 | p53 enhances gefitinib-induced growth inhibition and apoptosis by regulation of Fas in non-small cell lung cancer. | 2007 Feb 1 |
7 |
| 19 |
17404024 | The epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 (Iressa) suppresses proliferation and invasion of human oral squamous carcinoma cells via p53 independent and MMP, uPAR dependent mechanism. | 2007 Jan |
2 |
| 20 |
17490733 | Consequences of the loss of p53, RB1, and PTEN: relationship to gefitinib resistance in endometrial cancer. | 2007 Jul |
2 |
| 21 |
16166444 | Molecular alterations in tumors and response to combination chemotherapy with gefitinib for advanced colorectal cancer. | 2005 Sep 15 |
1 |